A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence
dc.contributor.author | Ruíz Moleón, Vera | |
dc.contributor.author | Fotouhi, Maryam | |
dc.contributor.author | Alende, Charles | |
dc.contributor.author | Ayoubi, Riham | |
dc.contributor.author | Bedford, Logan M. | |
dc.contributor.author | Southern, Kathleen | |
dc.contributor.author | Richardson, Timothy I. | |
dc.contributor.author | Laflamme, Carl | |
dc.contributor.author | NeuroSGC/YCharOS/EDDU collaborative group | |
dc.contributor.author | ABIF consortium | |
dc.contributor.department | Pharmacology and Toxicology, School of Medicine | |
dc.date.accessioned | 2024-11-12T09:07:31Z | |
dc.date.available | 2024-11-12T09:07:31Z | |
dc.date.issued | 2024-01-18 | |
dc.description.abstract | Phosphatidylinositol-specific phospholipase C gamma 2 (PLC-gamma-2) is an enzyme that regulates the function of immune cells. PLC-gamma-2 has been implicated in neurodegenerative and autoimmune disorders, yet investigation of this protein has been limited by a lack of independently characterized antibodies. Here we have characterized eleven PLC-gamma-2 commercial antibodies for use in Western Blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Ruíz Moleón V, Fotouhi M, Alende C, et al. A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Res. 2024;13:77. Published 2024 Jan 18. doi:10.12688/f1000research.146156.1 | |
dc.identifier.uri | https://hdl.handle.net/1805/44487 | |
dc.language.iso | en_US | |
dc.publisher | Taylor & Francis | |
dc.relation.isversionof | 10.12688/f1000research.146156.1 | |
dc.relation.journal | F1000Research | |
dc.rights | Attribution 4.0 International | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.source | PMC | |
dc.subject | Phosphatidylinositol-specific phospholipase C gamma 2 | |
dc.subject | Antibody characterization | |
dc.subject | Antibody validation | |
dc.subject | Western Blot | |
dc.subject | Immunoprecipitation | |
dc.subject | Immunofluorescence | |
dc.title | A guide to selecting high-performing antibodies for PLC-gamma-2 for use in Western Blot, immunoprecipitation and immunofluorescence | |
dc.type | Article |